investorscraft@gmail.com

Intrinsic Value of Catalyst Biosciences, Inc. (CBIO)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %-89.2NaN
Revenue, $1NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m9NaN
Operating income, $m-9NaN
EBITDA, $m-8NaN
Interest expense (income), $mNaN
Earnings before tax, $m-8NaN
Tax expense, $m0NaN
Net income, $m-8NaN

BALANCE SHEET

Cash and short-term investments, $m22NaN
Total assets, $m28NaN
Adjusted assets (=assets-cash), $m7NaN
Average production assets, $m0NaN
Working capital, $m11NaN
Total debt, $m0NaN
Total liabilities, $m17NaN
Total equity, $m12NaN
Debt-to-equity ratio0.003NaN
Adjusted equity ratio-1.477NaN

CASH FLOW

Net income, $m-8NaN
Depreciation, amort., depletion, $m0NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-33NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m0NaN
Free cash flow, $m-34NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m11
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount